Healthcare >> Analyst Interviews >> December 13, 1999
JAMES CULVERWELL attained a Bachelor of Science Honours degree in 1979.
He joined ABN Amro in 1982, where he spent 12 years as Head of European
Pharmaceutical and Healthcare Research. He joined Merrill Lynch in 1994
in a similar role and helped establish Merrill Lynch as a leading
investment advisor in European pharmaceutical companies. He and his
team have been consistently ranked in Institutional Investor surveys
over the past 15 years. He is 42 years of age. Profile
stocks that you follow?
Mr. Culverwell: I cover the pan European large-cap pharmaceutical stocks
and one or two of the
